These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2952408)
1. Prevalence of morning hyperglycaemia: determinants of fasting blood glucose concentrations in insulin-treated diabetics. Francis AJ; Home PD; Walford S; Alberti KG; Mann N; Reeves WG Diabet Med; 1985 Mar; 2(2):89-94. PubMed ID: 2952408 [TBL] [Abstract][Full Text] [Related]
2. Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin--a comparison of multiple injection regimens. Davies RR; McEwen J; Moreland TA; Durnin C; Newton RW Diabet Med; 1988 Oct; 5(7):671-5. PubMed ID: 2975553 [TBL] [Abstract][Full Text] [Related]
3. Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulin. Parillo M; Mura A; Iovine C; Rivellese AA; Lavicoli M; Riccardi G Diabetes Care; 1992 Feb; 15(2):173-7. PubMed ID: 1547673 [TBL] [Abstract][Full Text] [Related]
4. Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes. Turner D; Luzio S; Gray BJ; Bain SC; Hanley S; Richards A; Rhydderch DC; Martin R; Campbell MD; Kilduff LP; West DJ; Bracken RM Diabet Med; 2016 Apr; 33(4):506-10. PubMed ID: 26220149 [TBL] [Abstract][Full Text] [Related]
5. Free insulin profiles in insulin-dependent diabetics treated with one or two insulin injections per day. Olsson PO; Arnqvist H; von Schenck H Acta Med Scand; 1986; 220(2):133-41. PubMed ID: 3535391 [TBL] [Abstract][Full Text] [Related]
6. Human ultralente insulin: a comparison with porcine lente insulin as a twice-daily insulin in insulin-dependent diabetic patients with fasting hyperglycaemia. Francis AJ; Hanning I; Alberti KG Diabetes Res; 1986 Jun; 3(5):263-8. PubMed ID: 3527523 [TBL] [Abstract][Full Text] [Related]
7. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes. Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092 [TBL] [Abstract][Full Text] [Related]
8. Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin. Riccio A; Avogaro A; Valerio A; Zappella A; Tiengo A; Del Prato S Diabetes Care; 1994 Jun; 17(6):535-40. PubMed ID: 8082521 [TBL] [Abstract][Full Text] [Related]
9. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour? Radziuk J; Pye S Diabetologia; 2006 Jul; 49(7):1619-28. PubMed ID: 16752180 [TBL] [Abstract][Full Text] [Related]
10. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Ahmed AB; Home PD Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967 [TBL] [Abstract][Full Text] [Related]
11. Nocturnal blood glucose control in type I diabetes mellitus. Bolli GB; Perriello G; Fanelli CG; De Feo P Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480 [TBL] [Abstract][Full Text] [Related]
12. Fasting hyperglycemia and associated free-insulin and cortisol changes in Somogyi-like patients. Schmidt MI; Hadji-Georgopoulos A; Rendell M; Margolis S; Kowarski D; Kowarski AA Diabetes Care; 1979 Dec; 2(6):457-464. PubMed ID: 26922819 [TBL] [Abstract][Full Text] [Related]
13. [Early-morning hyperglycemia in patients with diabetes mellitus types 1 and 2]. Jasik M Wiad Lek; 1989 Apr; 42(8):529-32. PubMed ID: 2697976 [TBL] [Abstract][Full Text] [Related]
14. Treatment of early-morning hyperglycemia in type 1 diabetics with amorphous zinc insulin (Semilente) at bedtime. Strasser D; Nützi E; Spinas GA; Berger W Horm Res; 1993; 39(5-6):173-8. PubMed ID: 8314199 [TBL] [Abstract][Full Text] [Related]
15. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact? Choudhary P; Davies C; Emery CJ; Heller SR Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623 [TBL] [Abstract][Full Text] [Related]
16. Roles of site and timing of the morning insulin injection in type 1 diabetes. Witt MF; White NH; Santiago JV J Pediatr; 1983 Oct; 103(4):528-33. PubMed ID: 6352884 [TBL] [Abstract][Full Text] [Related]
17. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810 [TBL] [Abstract][Full Text] [Related]
18. Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. Trovati M; Ponziani MC; Massucco P; Anfossi G; Mularoni EM; Burzacca S; Tassone F; Perna P; Traversa M; Cavalot F Eur J Clin Invest; 2002 Mar; 32(3):179-86. PubMed ID: 11895469 [TBL] [Abstract][Full Text] [Related]
19. Ketone bodies as markers for type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control. Harano Y; Kosugi K; Hyosu T; Suzuki M; Hidaka H; Kashiwagi A; Uno S; Shigeta Y Diabetologia; 1984 May; 26(5):343-8. PubMed ID: 6376243 [TBL] [Abstract][Full Text] [Related]
20. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics. Asplin CM; Hartog M; Goldie DJ Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]